LifeSciences British Columbia Appoints Don Enns as President

LifeSciences British Columbia Appoints Don Enns as President
August 31, 2010
Vancouver, British Columbia - Industry association LifeSciences British Columbia is pleased to announce the appointment of Mr. Don Enns as the new President of the organization effective September 7th, 2010.

Mr. Enns has been a leader in British Columbia's life sciences industry for over 25 years, most recently as President and CEO of CANTEST Ltd., a BC-headquartered global organization providing professional analytical and clinical services in support of environmental quality, pharmaceutical, biotechnology and food safety industries as well as related projects for business and government.

"I am extremely proud to be appointed to this position, and recognize both the challenges and opportunities associated with further developing the life sciences sector in BC at this pivotal point in time," commented Mr. Enns. "LifeSciences BC plays a vital role in ensuring that British Columbia continues to be a globally recognized life sciences jurisdiction and leading knowledge-based economy. I look forward to working with all of LSBC's members, sponsors and partners to further build on this strong foundation."

Dr. Simon Pimstone, Chair of LifeSciences BC remarked, "On behalf of the Board of Directors, I would like to welcome Don to the organization. Don has been a highly respected member of our industry for many years and through his numerous achievements and contributions both locally and internationally, he has proven himself to be an impressive leader of the highest caliber. I know he will be a tremendous asset to LSBC and to the entire life sciences community in this province."

Mr. Enns received his MBA from UBC in 1987 and his Bachelor of Science Chemistry from TWU in 1982. He is a Director for numerous local companies and non-profit organizations involved with technology development, education, community enhancement and environmental sustainability. He currently serves as a Director or Committee Advisor to Genome British Columbia, the World Wildlife Fund and two UBC faculties amongst other organizations.

- 30 -

About LifeSciences BC
LifeSciences British Columbia is a not-for-profit, non-government association that represents and supports the biopharmaceutical, medical device, bioproducts, bioenergy and greater life sciences community of British Columbia through advocacy, education, facilitation of partnering and investment, and promotion of our world-class science and industry.


Contact:

Barry Gee
Senior Director, Operations and Communications
LifeSciences BC
tel: 604-602-5226
email: [email protected]

Suggested Articles

Xcovery's ALK inhibitor shrank tumors in 75% of lung cancer patients, compared to 67% for Pfizer's Xalkori, the first FDA-approved drug of that class.

The FDA accepted the regulatory filing for Biogen's once-failed Alzheimer's drug, aducanumab, with plans to decide its fate by March 7, 2021.

Alexion named a chief diversity officer, while COVID-19 vaccine player has two new members of its C-suite.